Posts Tagged ‘PBE’
-
Health Care Reform and Biotech ETFs: Will There Be Opportunities?
June 27th by Tom Lydon
In an attempt to reduce costs in the health care industry, the government will be legislating for... -
Why Biotech ETFs May Be the Better Choice
June 17th by Tom Lydon
Biotechnology stocks present opportunities, but given the unique challenges of the sector,... -
Can Obama’s Push Reignite Biotech and Health Care ETFs?
June 15th by Tom Lydon
Biotechnology and health care-related exchange traded funds (ETFs) could be set to take off as... -
Health Care ETFs’ $140 Billion Boost
February 19th by Tom Lydon
When President Barack Obama put his John Hancock on the $787 billion stimulus package, $140 billion... -
PowerShares’ ETF Family Grows With Biotech, Commodities
September 18th by Tom Lydon
The PowerShares exchange traded fund (ETF) family is adding a slew of new members this week.
The... -
Genentech Holds Out for Better Offer, Which Could Deliver a Boost to Biotech ETFs
August 14th by Tom Lydon
-
Biotech ETFs Are a Matter of Personal Choice
July 27th by Tom Lydon
Biotechnology appeals to many investors, and with four different exchange traded funds (ETFs)...
Biotechnology stocks and exchange traded funds (ETFs) could get a shot in the arm, as Genentech (
